Abstract
Ten adult patients in status asthmaticus were randomized to a controlled, double-blind, prospective trial of 20 mg vs 125 mg of methylprednisolone sodium succinate given intravenously every six hours for seven days. Individual responses were variable, but the magnitude and pattern of mean spirometric improvement in both groups were not significantly different The study revealed no apparent advantage in using the higher dosage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
